Completion of export-sourcing orders aggregating Rs. 299.91 Crores

Export Order Hard CurrencyBusiness Updates View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+5.7%Reaction day

₹1.06

prior close

₹1.10

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.1%+5.8% vs market

Pharmaceuticals peers, median of 151sector-0.5%+6.1% vs sector

On the reaction day the stock moved 5.8 pts more than Nifty Microcap 250 and 6.1 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+1.8

10m

-0.9

15m

+1.8

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+5.7-0.1+5.8-0.5+6.1

Next day

+11.3+0.4+11.0-0.2+11.6

+17.0+0.7+16.2-0.4+17.4

+10.4+0.2+10.2-0.9+11.2

+5.7+0.4+5.3+0.2+5.5

+0.0+1.6-1.6+0.9-0.9

+0.0+2.4-2.4+2.3-2.3

15d

-17.9-0.6-17.3-0.0-17.9

-13.2-4.6-8.7-4.6-8.6

-14.2-2.1-12.0-4.0-10.1

-40.6-3.5-37.0-6.6-34.0

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 151Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Welcure Drugs & Pharmaceuticals Ltd has announced the completion of export-sourcing orders totalling Rs. 299.91 Crores. The orders were sourced from international buyers and have been fully executed by the company. This is a significant milestone given the size of the order book fulfilled. The company operates in the pharmaceutical sector and this reinforces its export capabilities and order execution strength.

Likely market impact

Positive for shareholders as completion of Rs. 299.91 Crores in export orders supports revenue recognition and demonstrates the company's ability to secure and deliver large international contracts, which may boost investor confidence.